Streptococcal bacteraemia in patients submitted to hematopoietic stem cell transplantation : the role of tooth brushing and use of chlorhexidine by Antunes, Héliton Spíndola et al.
e303
Med Oral Patol Oral Cir Bucal. 2010 Mar 1;15 (2):e303-9.                                                                                                                                                        Oral hygiene and infection prevention
Journal section: Oral Medicine and Pathology                                                                                                             doi:10.4317/medoral.15.e303
Publication Types: Research
Streptococcal bacteremia in patients submitted to hematopoietic stem cell 
transplantation: The role of tooth brushing and use of chlorhexidine
 
Héliton-Spíndola Antunes 1, Elza-Maria de Sá Ferreira 2, Lúcia-Maria-Dias de Faria 3, Marcelo Schirmer 4, 
Pedro-Carvalho Rodrigues 5, Isabele-Ávila Small 1, Marta Colares 4, Luis-Fernando-da Silva Bouzas 4, Car-
los-Gil Ferreira 1
1 DDS, MSc, PT, MSc, MDS, PhD. Clinical Research Service, Instituto Nacional de Câncer (INCA), Rio de Janeiro, Brazil
Department of Stomatology, Dental School, Universidade do Grande Rio (UNIGRANRIO), Rio de Janeiro, Brazil
2 DDS, MSc.Consultant Professor, Dental School,UNIGRANRIO, Rio de Janeiro, Brazil
3 Biol.Microbiology Laboratory, INCA, Rio de Janeiro, Brazil
4 MDS, MDS, MSc, MDS, PhD.  Bone Marrow Transplant Center (CEMO), INCA, Rio de Janeiro, Brazil
5 PhD Therapy and Technology Development Section, INCA, Rio de Janeiro, Brazil
Correspondence: 
Serviço de Pesquisa Clínica
Instituto Nacional de Câncer (INCA)
Rua André Cavalcante, nº 37, 2º andar.
Rio de Janeiro, Brazil. CEP-20231-050
hspindola@inca.gov.br
  
Received: 30/01/2009
Accepted: 12/09/2009
Antunes H, Ferreira E, Faria L, Schirmer M, Rodrigues P, Small I, Co-
lares M, Bouzas L, Ferreira C. Streptococcal bacteremia in patients sub-
mitted to hematopoietic stem cell transplantation: The role of tooth bru-
shing and use of chlorhexidine. Med Oral Patol Oral Cir Bucal. 2010 Mar 
1;15 (2):e303-9.     
 http://www.medicinaoral.com/medoralfree01/v15i2/medoralv15i2p303.pdf
Abstract 
A retrospective evaluation of 73 consecutive recipients of hematopoietic stem cell transplantation (HSCT) was 
conducted to investigated the role of oral care and incidence of streptococcal bacteremia in patients submit-
ted to hematopoietic stem cell transplantation. Patients were retrospectively evaluated and divided into group A 
(GA=38) and group B (GB=35). During hospitalization patients from GA performed oral hygiene daily with extra 
soft toothbrush and toothpaste besides performing mouth cleaning with an ethanol-free 0.12% chlorhexidine solu-
tion tree times a day. In contrast GB patients performed mouth cleaning with extra soft toothbrush and toothpaste, 
but no chlorhexidine was used. Using the Chi square test it was observed that all patients from GA presented 
negative blood culture for alpha-hemolytic Streptococcus viridans and Candida albicans and only 1 patient wit-
hout oral mucositis from GB presented positive blood cultures for Streptococcus intermedius (p=0.48). The results 
indicate that methodology used for oral care before the HSCT and the practice of tooth brushing during the period 
were effective in preventing streptococcal bacteremia. Moreover, our data suggest that the mouth cleaning with 
chlorhexidine during HSCT may be not mandatory.
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Introduction
During hospitalization, patients who undergo a my-
eloablative chemotherapy protocol for hematopoietic 
stem cell transplantation (HSCT) develop neutropenia 
and therefore have a tendency to septicemia that can be 
originated in many sites of the organism (1). During the 
70s, gram-negative organisms were isolated with more 
frequency in blood cultures exams than the gram-posi-
tive (1-3). Since early 80s the scenario has changed, pre-
dominating gram-positive bacteria in blood cultures, 
especially α-hemolytic viridans streptococci varying 
from 10 to 70% (1) and coagulase-negative staphylo-
cocci (mainly Staphylococcus epidermidis) have been 
observed (2). 
The mouth bacteria field is made of several species of 
bacteria and fungi (4). Dental plaque formed by them 
has been defined by as “the nonmineralized microbial 
accumulation that adheres tenaciously to tooth surface, 
restorations, and prosthetic appliances, shows structural 
organization with predominance of filamentous forms, 
is composed of an organic matrix derived from salivary 
glycoproteins and extracellular microbial products, and 
cannot be removed by rinsing or water spray” (4). They 
present a complex composition with more than 500 spe-
cies and some are identified as the main causes of car-
ies, gingivitis and periodontal disease. The maximum 
concentration is found in bacterial plaque, where it is 
estimated that there are between 1011 and 1012 microor-
ganisms per gram of wet weight though there are also 
abundant bacteria on the back of the tongue and in the 
cheek and palatal mucosa. Although there are differ-
ences among the different oral ecosystems, globally the 
most abundant microorganisms are streptococci of the 
viridans group (5). Consequently, the thicker the plaque 
the greater to risk of infection (6). With a rich bacteria 
site in the oral cavity, specially gram-positive, there is a 
serious source of infection for the patient submitted to 
HSCT, since besides undergoing a severe immune sup-
pression, patients may suffer from oral mucositis (OM) 
that serves as a open door to micro organisms (2,7,8). 
Considering that oral and gastrointestinal mucositis 
may occur in up to 100% of the patients undergoing 
high-dose chemotherapy with HSCT (9), there is a high 
possibility for HSCT patients to acquire septicemia 
generated in the oral cavity.
The oral infection prevention must begin with the effort 
to reduce bacterial plaque and this can be achieved by 
the preparation of patients before hospitalization for the 
HSCT, through oral hygiene instructions, proper con-
ditioning of the oral cavity, removal of gum calculus, 
making necessary restorations and extracting teeth with 
bad prognostic (10). In the oral care before hospitaliza-
tion for the HSCT, a mouthwash with an ethanol-free 
0.12% chlorhexidine solution has become standard due 
to its efficacy in bacteria and fungi elimination (7,9).
In the current study, we investigated the role of oral care 
and incidence of streptococcal bacteremia in patients 
submitted to hematopoietic stem cell transplantation.  
Patients and Methods
This was as retrospective study, performed from Janu-
ary 4, 2004, and May 20, 2005. All patients (73) submit-
ted to HSCT at the “Centro de Transplante de Medula 
Óssea do Instituto Nacional de Câncer” (CEMO-INCA) 
were included. Patients were divided into group A 
(GA=38 patients) and group B (GB=35 patients). The 
study was conducted according to the resolution 196/96 
from the National Health Council and was approved by 
the local Ethics Committee. All patients signed an in-
formed consent and received all clarifications and ori-
entations. 
Inclusion and exclusion criteria
The criteria for inclusion in the study was defined as 
age ≥ 18 years old, patients with hematological disease 
and indication to HSCT, patients able to perform mouth 
cleaning (oral hygiene). Patients unable to perform 
mouth cleaning were excluded. 
* Method:
Oral care before hospitalization
All patients (GA e GB) were previously evaluated by 
the dentist and received dental care, whenever neces-
sary. Dental care included educating patients about oral 
hygiene; panoramic radiograph; oral examination with 
attention to soft tissues and bones; tooth and periodon-
tal exam; removal of sub and supragingival calculus; 
elimination of sources of trauma caused by orthodontic 
bands and brackets, teeth, or prosthesis; extraction of 
teeth with signs or symptoms indicative of potentially 
bad prognosis (active periodontal disease, teeth requir-
ing endodontic treatment or with extended caries and 
coronary destruction) (9,10). All patients from both 
groups performed oral hygiene after meals with tooth-
paste with fluoride and mouth washing with an etha-
nol-free 0.12% chlorhexidine solution during 15 days 
before hospitalization for the transplant, three times a 
day (morning, afternoon, and night).  Patients from both 
groups received 5 vials of chlorhexidine for a 15-day 
period. Drug countability of chlorhexidine was per-
formed, as well as, registration of the use in the patient 
charts.
Oral care during hospitalization
Patients from group A had participated in a phase III 
trial analyzing the impact of low power laser in the pre-
vention of oral mucositis, and they followed the proto-
col in which toothpaste and toothbrush were provided in 
the day of hospitalization. Further they performed with 
extra-soft toothbrushes, dental paste with a peroxidase 
system after every meal and mouth washing with an 
ethanol-free 0.12% chlorhexidine solution, 20 ml three 
times a day (morning, afternoon, and night), from the 
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conditioning (D-7) until neutrophil recovery (presence 
of 500 neutrophils in the peripheral blood for two con-
secutive days) (9). 
Patients from group B underwent HSCT in the same pe-
riod of the year, performed oral hygiene every meal at 
their discretion using extra-soft toothbrushes and tooth-
paste without peroxidase system but with fluoride and 
did not use mouth washing with an ethanol-free 0.12% 
chlorhexidine solution during the time of hospitaliza-
tion. It should be emphasized that patients from group 
B were not included in the LPLT trial at random due to 
accrual limitations. The interventions in groups A and 
B are summarized in (Fig. 1). 
Chemoprophilaxy
The patients from both groups used intravenously flu-
conazol 200 mg every 12 hours, acyclovir 500 mg/m² 
every 8 hours, both from D–2 until neutrophil recovery, 
sulfametoxazol + trimetropin every 12 hours from the 
hospitalization day until D-2 in order to prevent infec-
tion by Pneumocistis jirovecci (carini). There was no 
antibiotic prophylaxis specific for gram-positive and 
gram-negative in neither group. 
Systemic infection evaluation (Bacteremia)
Bacteremia was defined with the presence of at least 
one aerobic, anaerobic bacteria and fungi positive blood 
culture sample. Blood cultures were collected in both 
group patients during the first fever episode and sub-
sequent.
Blood cultures exam and microorganism identification
The analyses of the positive feature in the blood exam 
was made by automatic method with a BACTEC 9240 
(Becton Dickinson) and the identification were made by 
automatic method with a VITEK® (bioMérieux). 
Statistic analyses
The data were obtained through observation of results 
of the blood cultures during fever and correlated to the 
study group with the presence of OM (G2, G3 e G4-Oral 
Mucositis Index of the World Health Organization) (11) 
and use of the mouth washing with an ethanol-free 0.12% 
chlorhexidine solution during the time of hospitalization, 
using the chi-square test (χ2) and with the hospitalization 
time using the Student test. The statistical test applied 
to analyze the patient’s characteristics were Student test 
and chi-square test (χ2). A p-value ≤ 0.05 was considered 
significant.
Fig. 1. Characteristics of protocols. HSCT: Hematopoietic stem cell transplantation.
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Results   
Patient characteristics
The study group A consisted of 38 patients (28 Alloge-
neic and 10 Autologous), 23 male and 15 female, ran-
ging in age from 19 to 57 years (mean age, 36.7 years). 
Cancer diagnoses in this group included acute lym-
phoblastic leukemia (n=1), acute myeloblastic leukemia 
(n=6), chronic myeloblastic leukemia (n=16), Hodgkin’s 
lymphoma (n=8), Non-Hodgkin’s lymphoma (n=4) and 
myelodisplasic  syndrome (n=3).  The study group B 
consisted of 35 patients (21 Allogeneic and 14 Autolo-
gous), 18 male and 17 female, ranging in age from 19 
to 64 years (mean age, 34.1 years). Cancer diagnoses in 
this group included acute lymphoblastic leukemia (n=3), 
acute myeloblastic leukemia (n=4), chronic myeloblas-
tic leukemia (n=4), Hodgkin’s lymphoma (n=13), Non-
Hodgkin’s lymphoma (n=8) and myelodisplasic  syn-
drome (n=3). When the age (p=0.23), gender (p=0.43), 
HSCT (p=0.21) was compared between GA and GB 
no significant difference was observed. When the pri-
mary neoplasia (leukemia versus lymphomas versus 
myelodisplasic syndrome) was compared between GA 
and GB a significant statistical difference was observed 
(p= 0.04).
Blood culture
All patients presented fever at some point and so had 
blood samples collected for culture, which is a routine at 
CEMO. In total, 480 blood cultures (GA=245, GB=235) 
were performed with median of 5 exams for patient in 
GA and GB, respectively. The incidence of positive 
blood culture in both groups was not statistically diffe-
rent (p=0.63), (Table 1).
Blood culture, oral mucositis and use of the chlorhexi-
dine
Out of 38 patients in GA and 35 patients in GB only 9 
(23.6%) and 10 (28.6%) presented positives blood cul-
tures, respectively (p=0.63). 
In GA α-hemolytic viridans streptococci and fungi 
were not isolated, however in GB α-hemolytic viridans 
streptococci was isolated in 1 patient (p=0.48).
When the positivity of blood culture were compared bet-
ween GA (with chlorhexidine) and GB (without chlo-
rhexidine), considering the patients with OM G2, G3 e 
G4 (p=0.43) and without OM G2, G3 e G4 (p=0.77) no 
significant difference was observed (Table 1). The re-
sults showed that 5 patients from GA and 7 from GB 
that had OM and positive blood cultures results did not 
present positive results for viridans streptococci. The 
microorganisms isolated in patients with OM were: Ba-
cillus species, Enterobacter cloacae, Klebsiella pneumo-
niae, Pseudomonas aeruginosa, Staphylococcus aureus, 
Escherichia coli, Staphylococcus haemolyticus, Staphy-
lococcus epidermidis, Stenotrophomonas maltophilia. 
Further positive results for Streptococcus intermedius 
was observed in 1 patient without OM in GB (p=0.48). 
Oral mucositis and hospitalization length
When a correlation was established between patients 
submitted to HSCT allogeneic and autologous with OM, 
bacteremia and the hospitalization length, although pa-
tients submitted to HSCT allogeneic that presented bac-
teremia had a trend for a longer hospitalization (excess 
of 4 days) than those without bacteremia, no significant 
difference was seen  (Table 2); p=0.107).    
Blood cultures 
and OM
GROUP A
n=38
GROUP B
n=35 p
Positive blood 
cultures with OM 5 7 0.43
Positive blood 
cultures without 
OM
4 3 0.77
TOTAL 9 (23.6%) 10 (28.6%) 0.63
HSCT, n N Median (Max-Min) Mean (SD) p
Allogeneic with positive blood cultures 13 34 (74-20) 39.62 (17.50) .107
Allogeneic with negative blood cultures 30 30 (68-18) 30.83 ( 8.98 )
Allogeneic with oral mucositis 33 30 (70-21) 34.06 (11.62) .596
Alogeneic without oral mucositis 10 30.5 (74-18) 31.60 (16.13)
Autologous with positive blood cultures 4 19 (21-18) 19.25 ( 1.26) .525
Autologous with negative blood cultures 19 20 (32-17) 20.42 ( 3.52)
Autologous with oral mucositis 14 20.5 (32-17) 21.14 ( 3.71) .088
Autologous without oral mucositis 9 18 (22-17) 18.78 ( 1.64)
Allogeneic  (death) 6 ------------------------ --------------------- --------------
Autologous (death) 1 ---------------------- --------------------- --------------
Table 1. Positive blood cultures.
 Table 2. Duration of Hospital Stay Compared across HSCT.   
OM: Oral mucositis.
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Discussion
Even though the results of HSCT have been encourag-
ing, infectious complications still result in significant 
morbidity and mortality and remain major obstacles to 
further improvement of survival rates. Infections fol-
lowing HSCT are determined in part by the sequential 
events that occur in the process of marrow ablation, 
hematopoietic engraftment and immunologic recovery. 
Moreover, most of the bacteria and yeasts enter the host 
via a damaged integument either through or gut or via 
an intravascular device or the oral cavity (2). 
Although different strategies of oral care have been 
evaluated in patients submitted to HSCT the impact of 
this oral care on Streptococcal bacteremia have been 
neglected. 
In this context, the aim of the present study was to 
evaluate in a retrospective manner the impact of oral 
care on Streptococcal bacteremia in patients submitted 
to HSCT. The oral hygiene protocol used in all patients 
for oral conditioning before the hospitalization for the 
HSCT included oral hygiene orientation, supplemen-
tation of toothpaste and toothbrush and the use of an 
ethanol-free 0.12% chlorhexidine solution during 15 
days. The protocol used during hospitalization included 
toothpaste, toothbrush and use or not of chlorhexidine 
(GA and GB, respectively). 
The goal of this strategy was to reduce the microor-
ganisms from the mouth to the background that comes 
from Listgarten (4) who quotes that the higher the den-
tal plaque volume, the higher the quantity and quality 
of microorganisms. Goodson et al. (6) also states that 
the effectiveness of the mechanical cleaning associated 
with the hygiene instruction in the recovery or mainte-
nance of oral health and that the mechanical removal 
diminishes the quantity of bacteria but it does not alter 
the dental plaque composition.
It was chosen to use 0.12% chlorhexidine solution to alter 
the quantity of microbiota and inhibit the dental plaque 
formation and consequently prevent gum diseases. The 
activity of chlorhexidine has been defined elsewhere, 
with activity against gram-positive, gram-negative and 
some fungi. Further when used as mouthwash at 0.12%, 
it reduce several species of the bacteria in saliva (12).
In the current study, blood cultures results showed that 
there were no statistically significant difference between 
patients who used chlorhexidine during hospitalization 
(GA=23.6%) and patients that did not use chlorhexidine 
(GB=28.6%). When the incidence of positive blood cul-
tures  was evaluated  in patients with OM and those 
ones who did not present OM in GA and GB, it was also 
observed that there was no statistically significant di-
fferences in the Groups. This data was contrary to data 
presented by other studies quoting OM as a cause of 
the bacteremia (1, 13-16). It is worth mentioning that 
out of 19 (26%) positive blood cultures in 73 patients, 
only 1 (1.36%) was positive for α-hemolytic viridans 
streptococci (Streptococcus intermedius) and that hap-
pened in a patient from GB, who did not presented OM. 
It must be pointed out that patients from this study did 
not receive antibacterial prophylaxis for gram-negative 
and gram-positive. This is contrary to data presented 
by Bilgrami et al. (13) who observed an incidence of 
17.5% of streptococci isolated from blood cultures in 
patients using prophylactic ampicillin and 19% in those 
without it. These authors also mention that all patients 
submitted themselves to: ciprofloxacin 500 mg, twice a 
day from D-10 till recovery neutrophil or the beginning 
of parenteral antibiotics, acyclovir 250 mg/m² from the 
conditioning until recovery neutrophil, mouthwashes 
with chlorhexidine 15 ml twice a day, mouthwash with 
nystatin, 1 million units 4 times a day and hydrogen 
peroxy diluted 4 times a day, but there was no informa-
tion about tooth brushing. 
The patients from both groups (A and B) did not present 
other issues as gum diseases, dental fracture, abscess 
both periapical and periodontal and the ones with OM 
presented positive blood cultures for some microorga-
nisms common in other sites, but that may be isolated 
in the oral cavity but we can not indicate their origin for 
not accomplishing oral swab. We observe that OM was 
not directly correlated to positive bacteremia strepto-
cocci, although evidence suggest that the breaking of 
oral mucous permits the penetration of microorganisms, 
which justifies the importance of the oral care, fact that 
was seen by Ruescher et al. (1), observed OM in 63% 
of patients with positive blood cultures for α-hemolytic 
streptococci, compared to only 36% of OM in patients 
without it. The authors assert that OM is a risk factor 
for bacteremia (odds ratio of 3:1) when compared to pa-
tients with intact mucous. It was also seen by Marron 
et al. (14), in patients with cancer, that quoted an inci-
dence of 18% of positive blood cultures for α-hemolytic 
viridans streptococci, in 485 episodes of bacteremia and 
when they isolated the following species: Streptococcus 
mitis (72 cases), Streptococcus salivarius (7), Strepto-
coccus sanguis (5), Streptococcus milleri (3), and Strep-
tococcus mutans (2). Thus, as the previous results, these 
authors did not refer to how the oral cavity was prepared 
before the HSCT. Graber et al. (15), stated all patients 
had dental evaluation and treatment as well as pano-
ramic radiography before the HSCT. In that study the 
patients received norfloxacin 400 mg / day from D-7 
till the neutrophil recovery. This author did not provide 
information about oral hygiene during HSCT and the 
results of this study showed an incidence of 33.9% (19 
in 56) for α-hemolytic viridans streptococci. 
It should be highlighted that oral care for both groups 
before HSCT was equal for all patients and they all 
brushed their teeth during hospital stay. Although tooth-
pastes were different, its composition may not have in-
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terfered on the results. Inconclusive evidence exists in 
the literature with regard to the additional (beneficial) 
mechanical effect of a dentifrice on plaque removal. 
Paraskevas et al. (17,18) affirm that the use of toothpaste 
did not contribute to mechanical plaque removal during 
manual toothbrushing and it seemed that the mechanical 
action provided by the toothbrush was the main factor 
in the plaque-removing process. Addy et al. (19) in 80s 
already showed that the triclosan toothpastes contain-
ing the copolymer and chlorhexidine solution, produced 
significant reductions on salivary bacterial counts and 
to correlate it with plaque inhibitory properties of anti-
microbial compounds. Assuming  groups A and B were 
homogeneous in age, gender, HSCT protocol, oral care 
before hospitalization and that low power laser ther-
apy (LPLT) is not bactericide, the relevant difference 
between the groups was the use of mouthwash with 
0,12% chlorhexidine during hospitalization in the GA. 
It should be highlighted though that LPLT is bactericide 
when used with photosensitizer (dye) as an anti-micro-
bial photodynamic therapy (20). The excellent results 
concerning bacteremia α-hemolytic viridans granted 
to the preparation of the oral cavity before HSCT and 
the maintenance of oral hygiene with toothbrush during 
HSCT.     
In this study all patients undergoing an HSCT either al-
logeneic or autologous with or without OM presented 
no difference in the time for hospitalization, regard-
less of the presence of bacteremia. This is in contrast 
to Ruescher et al. (1) who says that when independently 
analyzed the patients with OM stayed hospitalized for a 
longer period (39.7 days) than those without OM (34.4 
days).
In our hands, the patients submitted to HSCT allogeneic 
that presented bacteremia had a trend for a longer hospi-
talization, however this was not statistically significant, 
probably due to small sample size. This is in line with 
Ruescher et al. (1) who states that patients with sepsis 
stayed in hospital 10 days more than those without it 
and Vera-Llonch et al. (16) refer that there was a 14-day 
difference in the length of hospital stay between patients 
with the highest OM grade and those with OM grade 
0. In a conservative evaluation on a hypothetical popu-
lation of 100 patients, Ruesher et al. (1) estimates that 
15% of transplanted patients presented infection with 
streptococci and that 45% presented OM. It also says 
that patients with OM and sepsis, when compared to pa-
tients with OM without sepsis, has the hospital stay in-
creased in 11 days, resulting in an additional cost of U$ 
544,500 e U$4500 per day/patient. Following the same 
line Vera-Llonch et al. (16) also observed a cost increase 
in cases that the patient presented OM (U$ 437,421) 
against the ones without OM (U$ 213,995). They state 
that the patient with OM has other co-morbidity as: e.g., 
gastrointestinal bleeding, volume depletion, cardiac 
failure. Although it may represent a flaw in our study we 
chose not to estimate eventual cost increase because we 
understand that the transplanted patient presents other 
co-morbidity which may interfere in the length of hos-
pital stay such as the recovery neutrophil, graft-versus-
host disease, cardiac insufficiency, hepatic insufficien-
cy, kidney insufficiency, gastrointestinal bleeding since 
these data was not collected prospectively its evaluation 
could lead to a bias.
In conclusion, no significant difference for streptococ-
cal bacteremia between GA and GB, moreover overall 
a lower incidence was observed. Despite the non-rand-
omized nature of this study, our data suggests that the 
dominant factor for this result was the oral care approach 
before the hospitalization for HSCT based in the practice 
of necessary dental treatment and adequate oral hygiene 
measurements (toothbrushing and the mouth washing 
with 0.12% chlorhexidine) and maintenance of the oral 
hygiene with the toothbrush during it. The proceeding 
of mouth washing with 0.12% chlorhexidine during the 
length of hospital stay for HSCT may be unnecessary. 
It would be interesting to confirm that in a randomized 
trial addressing also potential cost-effectiveness impli-
cations.
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